{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:18:18Z","timestamp":1781241498230,"version":"3.54.1"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chunhong Li","award":["Sichuan Science and Technology Program (grant numbers 2023NSFSC0620, 2022YFS0614, 2022YFS0622)"],"award-info":[{"award-number":["Sichuan Science and Technology Program (grant numbers 2023NSFSC0620, 2022YFS0614, 2022YFS0622)"]}]},{"name":"Chunxiang Zhang","award":["National Natural Science Foundation of China (Grant Nos. U23A20398)"],"award-info":[{"award-number":["National Natural Science Foundation of China (Grant Nos. U23A20398)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02079-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:01:49Z","timestamp":1756105309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in fibroblast-based cardiac reprogramming in the treatment of heart disease"],"prefix":"10.1007","volume":"74","author":[{"given":"Yuanyuan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"2079_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 2018;15:585\u2013600. https:\/\/doi.org\/10.1038\/s41569-018-0036-6.","journal-title":"Nat Rev Cardiol"},{"key":"2079_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117:1450\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvaa324.","journal-title":"Cardiovasc Res"},{"key":"2079_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","volume":"70","author":"J Davis","year":"2014","unstructured":"Davis J, Molkentin JD. Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol. 2014;70:9\u201318. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.10.019.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091386","author":"H Venugopal","year":"2022","unstructured":"Venugopal H, Hanna A, Humeres C, Frangogiannis NG. Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11091386.","journal-title":"Cells"},{"key":"2079_CR5","doi-asserted-by":"publisher","first-page":"637538","DOI":"10.3389\/fbioe.2020.637538","volume":"8","author":"AS Riching","year":"2020","unstructured":"Riching AS, Song K. Cardiac regeneration: new insights into the frontier of ischemic heart failure therapy. Front Bioeng Biotechnol. 2020;8:637538. https:\/\/doi.org\/10.3389\/fbioe.2020.637538.","journal-title":"Front Bioeng Biotechnol"},{"key":"2079_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197\u2013210. https:\/\/doi.org\/10.1016\/s0140-6736(16)30677-8.","journal-title":"Lancet"},{"key":"2079_CR7","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1021\/acsanm.9b02586","volume":"3","author":"P Muniyandi","year":"2020","unstructured":"Muniyandi P, Palaninathan V, Mizuki T, Maekawa T, Hanajiri T, Mohamed S. Poly(lactic-co-glycolic acid)\/polyethylenimine nanocarriers for direct genetic reprogramming of microRNA targeting cardiac fibroblasts. ACS Appl Nano Mater. 2020;3:2491\u2013505. https:\/\/doi.org\/10.1021\/acsanm.9b02586.","journal-title":"ACS Appl Nano Mater"},{"key":"2079_CR8","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.nano.2022.102589","volume":"45","author":"L Nicoletti","year":"2022","unstructured":"Nicoletti L, Paoletti C, Tarricone G, Andreana I, Stella B, Arpicco S, Divieto C, Mattu C, Chiono V. Lipoplexes for effective in vitro delivery of microRNAs to adult human cardiac fibroblasts for perspective direct cardiac cell reprogramming. Nanomed Nanotechnol Biol Med. 2022;45:102589. https:\/\/doi.org\/10.1016\/j.nano.2022.102589.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"2079_CR9","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","volume":"184","author":"MV Plikus","year":"2021","unstructured":"Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, Driskell RR, Rosenthal N, Biernaskie J, Horsley V. Fibroblasts: origins, definitions, and functions in health and disease. Cell. 2021;184:3852\u201372. https:\/\/doi.org\/10.1016\/j.cell.2021.06.024.","journal-title":"Cell"},{"key":"2079_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/circresaha.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D\u2019Antoni ML, Debuque R, Chandran A, Wang L, Arora K, Rosenthal NA, et al. Revisiting cardiac cellular composition. Circ Res. 2016;118:400\u20139. https:\/\/doi.org\/10.1161\/circresaha.115.307778.","journal-title":"Circ Res"},{"key":"2079_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","volume":"588","author":"M Litvi\u0148ukov\u00e1","year":"2020","unstructured":"Litvi\u0148ukov\u00e1 M, Talavera-L\u00f3pez C, Maatz H, Reichart D, Worth CL, Lindberg EL, Kanda M, Polanski K, Heinig M, Lee M, et al. Cells of the adult human heart. Nature. 2020;588:466\u201372. https:\/\/doi.org\/10.1038\/s41586-020-2797-4.","journal-title":"Nature"},{"key":"2079_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10:15\u201326. https:\/\/doi.org\/10.1038\/nrcardio.2012.158.","journal-title":"Nat Rev Cardiol"},{"key":"2079_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0092-8674(79)90317-9","volume":"17","author":"SM Taylor","year":"1979","unstructured":"Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1\/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771\u20139. https:\/\/doi.org\/10.1016\/0092-8674(79)90317-9.","journal-title":"Cell"},{"key":"2079_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/circresaha.115.308136","volume":"119","author":"R Lombardi","year":"2016","unstructured":"Lombardi R, Chen SN, Ruggiero A, Gurha P, Czernuszewicz GZ, Willerson JT, Marian AJ. Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene. Circ Res. 2016;119:41\u201354. https:\/\/doi.org\/10.1161\/circresaha.115.308136.","journal-title":"Circ Res"},{"key":"2079_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature13839","volume":"514","author":"E Ubil","year":"2014","unstructured":"Ubil E, Duan J, Pillai IC, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514:585\u201390. https:\/\/doi.org\/10.1038\/nature13839.","journal-title":"Nature"},{"key":"2079_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142:375\u201386. https:\/\/doi.org\/10.1016\/j.cell.2010.07.002.","journal-title":"Cell"},{"key":"2079_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2010.02.011","volume":"20","author":"B van Wijk","year":"2010","unstructured":"van Wijk B, van den Hoff M. Epicardium and myocardium originate from a common cardiogenic precursor pool. Trends Cardiovasc Med. 2010;20:1\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2010.02.011.","journal-title":"Trends Cardiovasc Med"},{"key":"2079_CR18","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/circresaha.112.269035","volume":"110","author":"TM Jayawardena","year":"2012","unstructured":"Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ. Microrna-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110:1465\u201373. https:\/\/doi.org\/10.1161\/circresaha.112.269035.","journal-title":"Circ Res"},{"key":"2079_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024.","journal-title":"Cell"},{"key":"2079_CR20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1164270","volume":"322","author":"K Okita","year":"2008","unstructured":"Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322:949\u201353. https:\/\/doi.org\/10.1126\/science.1164270.","journal-title":"Science"},{"key":"2079_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1162494","volume":"322","author":"M Stadtfeld","year":"2008","unstructured":"Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008;322:945\u20139. https:\/\/doi.org\/10.1126\/science.1162494.","journal-title":"Science"},{"key":"2079_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature09871","volume":"471","author":"SM Hussein","year":"2011","unstructured":"Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, N\u00e4rv\u00e4 E, Ng S, Sourour M, H\u00e4m\u00e4l\u00e4inen R, Olsson C, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011;471:58\u201362. https:\/\/doi.org\/10.1038\/nature09871.","journal-title":"Nature"},{"key":"2079_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nbt.1554","volume":"27","author":"K Miura","year":"2009","unstructured":"Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009;27:743\u20135. https:\/\/doi.org\/10.1038\/nbt.1554.","journal-title":"Nat Biotechnol"},{"key":"2079_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474:212\u20135. https:\/\/doi.org\/10.1038\/nature10135.","journal-title":"Nature"},{"key":"2079_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-x","volume":"51","author":"RL Davis","year":"1987","unstructured":"Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987;51:987\u20131000. https:\/\/doi.org\/10.1016\/0092-8674(87)90585-x.","journal-title":"Cell"},{"key":"2079_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S\u00fcdhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035\u201341. https:\/\/doi.org\/10.1038\/nature08797.","journal-title":"Nature"},{"key":"2079_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/circulationaha.113.007727","volume":"130","author":"JK Han","year":"2014","unstructured":"Han JK, Chang SH, Cho HJ, Choi SB, Ahn HS, Lee J, Jeong H, Youn SW, Lee HJ, Kwon YW, et al. Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. Circulation. 2014;130:1168\u201378. https:\/\/doi.org\/10.1161\/circulationaha.113.007727.","journal-title":"Circulation"},{"key":"2079_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nature09591","volume":"468","author":"E Szabo","year":"2010","unstructured":"Szabo E, Rampalli S, Risue\u00f1o RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010;468:521\u20136. https:\/\/doi.org\/10.1038\/nature09591.","journal-title":"Nature"},{"key":"2079_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature10116","volume":"475","author":"P Huang","year":"2011","unstructured":"Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature. 2011;475:386\u20139. https:\/\/doi.org\/10.1038\/nature10116.","journal-title":"Nature"},{"key":"2079_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ncb2164","volume":"13","author":"JA Efe","year":"2011","unstructured":"Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol. 2011;13:215\u201322. https:\/\/doi.org\/10.1038\/ncb2164.","journal-title":"Nat Cell Biol"},{"key":"2079_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/cr.2015.99","volume":"25","author":"Y Fu","year":"2015","unstructured":"Fu Y, Huang C, Xu X, Gu H, Ye Y, Jiang C, Qiu Z, Xie X. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res. 2015;25:1013\u201324. https:\/\/doi.org\/10.1038\/cr.2015.99.","journal-title":"Cell Res"},{"key":"2079_CR32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.aaf1502","volume":"352","author":"N Cao","year":"2016","unstructured":"Cao N, Huang Y, Zheng J, Spencer CI, Zhang Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, et al. Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 2016;352:1216\u201320. https:\/\/doi.org\/10.1126\/science.aaf1502.","journal-title":"Science"},{"key":"2079_CR33","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1101\/gad.305482.117","volume":"31","author":"H Zhou","year":"2017","unstructured":"Zhou H, Morales MG, Hashimoto H, Dickson ME, Song K, Ye W, Kim MS, Niederstrasser H, Wang Z, Chen B, et al. ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression. Genes Dev. 2017;31:1770\u201383. https:\/\/doi.org\/10.1101\/gad.305482.117.","journal-title":"Genes Dev"},{"key":"2079_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.celrep.2014.01.038","volume":"6","author":"H Wang","year":"2014","unstructured":"Wang H, Cao N, Spencer CI, Nie B, Ma T, Xu T, Zhang Y, Wang X, Srivastava D, Ding S. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep. 2014;6:951\u201360. https:\/\/doi.org\/10.1016\/j.celrep.2014.01.038.","journal-title":"Cell Rep"},{"key":"2079_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.stemcr.2024.08.002","volume":"19","author":"K Nakano","year":"2024","unstructured":"Nakano K, Sadahiro T, Fujita R, Isomi M, Abe Y, Yamada Y, Akiyama T, Honda S, French BA, Mizukami H, et al. Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming. Stem Cell Rep. 2024;19:1389\u201398. https:\/\/doi.org\/10.1016\/j.stemcr.2024.08.002.","journal-title":"Stem Cell Rep"},{"key":"2079_CR36","doi-asserted-by":"publisher","first-page":"e005652","DOI":"10.1161\/jaha.112.005652","volume":"1","author":"M Mathison","year":"2012","unstructured":"Mathison M, Gersch RP, Nasser A, Lilo S, Korman M, Fourman M, Hackett N, Shroyer K, Yang J, Ma Y, et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012;1:e005652. https:\/\/doi.org\/10.1161\/jaha.112.005652.","journal-title":"J Am Heart Assoc"},{"key":"2079_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/circresaha.116.304510","volume":"116","author":"TM Jayawardena","year":"2015","unstructured":"Jayawardena TM, Finch EA, Zhang L, Zhang H, Hodgkinson CP, Pratt RE, Rosenberg PB, Mirotsou M, Dzau VJ. Microrna induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res. 2015;116:418\u201324. https:\/\/doi.org\/10.1161\/circresaha.116.304510.","journal-title":"Circ Res"},{"key":"2079_CR38","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/ijn.S304873","volume":"16","author":"L Yang","year":"2021","unstructured":"Yang L, Xue S, Du M, Lian F. Highly efficient microRNA delivery using functionalized carbon dots for enhanced conversion of fibroblasts to cardiomyocytes. Int J Nanomed. 2021;16:3741\u201354. https:\/\/doi.org\/10.2147\/ijn.S304873.","journal-title":"Int J Nanomed"},{"key":"2079_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41422-018-0036-4","volume":"28","author":"C Huang","year":"2018","unstructured":"Huang C, Tu W, Fu Y, Wang J, Xie X. Chemical-induced cardiac reprogramming in vivo. Cell Res. 2018;28:686\u20139. https:\/\/doi.org\/10.1038\/s41422-018-0036-4.","journal-title":"Cell Res"},{"key":"2079_CR40","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/circulationaha.122.062810","volume":"148","author":"J Wu","year":"2023","unstructured":"Wu J, Zhao H, Tao Y, Yang C, Yang Y, Zhou B, Zhao Y. Improved factor combination for in vivo reprogramming of cardiac myofibroblast to cardiomyocyte-like cell with dual recombinase tracing. Circulation. 2023;148:1728\u201331. https:\/\/doi.org\/10.1161\/circulationaha.122.062810.","journal-title":"Circulation"},{"key":"2079_CR41","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.ymthe.2021.07.014","volume":"29","author":"K Kaur","year":"2021","unstructured":"Kaur K, Hadas Y, Kurian AA, \u017bak MM, Yoo J, Mahmood A, Girard H, Komargodski R, Io T, Santini MP, et al. Direct reprogramming induces vascular regeneration post muscle ischemic injury. Mol Ther. 2021;29:3042\u201358. https:\/\/doi.org\/10.1016\/j.ymthe.2021.07.014.","journal-title":"Mol Ther"},{"key":"2079_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/circresaha.112.271148","volume":"111","author":"K Inagawa","year":"2012","unstructured":"Inagawa K, Miyamoto K, Yamakawa H, Muraoka N, Sadahiro T, Umei T, Wada R, Katsumata Y, Kaneda R, Nakade K, et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012;111:1147\u201356. https:\/\/doi.org\/10.1161\/circresaha.112.271148.","journal-title":"Circ Res"},{"key":"2079_CR43","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1021\/acsomega.8b00904","volume":"3","author":"SY Yoo","year":"2018","unstructured":"Yoo SY, Jeong SN, Kang JI, Lee SW. Chimeric adeno-associated virus-mediated cardiovascular reprogramming for ischemic heart disease. ACS Omega. 2018;3:5918\u201325. https:\/\/doi.org\/10.1021\/acsomega.8b00904.","journal-title":"ACS Omega"},{"key":"2079_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/circulationaha.116.024692","volume":"135","author":"TM Mohamed","year":"2017","unstructured":"Mohamed TM, Stone NR, Berry EC, Radzinsky E, Huang Y, Pratt K, Ang YS, Yu P, Wang H, Tang S, et al. Chemical enhancement of in vitro and in vivo direct cardiac reprogramming. Circulation. 2017;135:978\u201395. https:\/\/doi.org\/10.1161\/circulationaha.116.024692.","journal-title":"Circulation"},{"key":"2079_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay7856","author":"L Wang","year":"2020","unstructured":"Wang L, Ma H, Huang P, Xie Y, Near D, Wang H, Xu J, Yang Y, Xu Y, Garbutt T, et al. Down-regulation of Beclin1 promotes direct cardiac reprogramming. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.aay7856.","journal-title":"Sci Transl Med"},{"key":"2079_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature11139","volume":"485","author":"K Song","year":"2012","unstructured":"Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485:599\u2013604. https:\/\/doi.org\/10.1038\/nature11139.","journal-title":"Nature"},{"key":"2079_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.stem.2017.11.010","volume":"22","author":"K Miyamoto","year":"2018","unstructured":"Miyamoto K, Akiyama M, Tamura F, Isomi M, Yamakawa H, Sadahiro T, Muraoka N, Kojima H, Haginiwa S, Kurotsu S, et al. Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction. Cell Stem Cell. 2018;22:91-103.e105. https:\/\/doi.org\/10.1016\/j.stem.2017.11.010.","journal-title":"Cell Stem Cell"},{"key":"2079_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1161\/circulationaha.122.061542","volume":"148","author":"H Zhou","year":"2023","unstructured":"Zhou H, Yang J, Srinath C, Zeng A, Wu I, Leon EC, Qureshi TN, Reid CA, Nettesheim ER, Xu E, et al. Improved cardiac function in postischemic rats using an optimized cardiac reprogramming cocktail delivered in a single novel adeno-associated virus. Circulation. 2023;148:1099\u2013112. https:\/\/doi.org\/10.1161\/circulationaha.122.061542.","journal-title":"Circulation"},{"key":"2079_CR49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41556-021-00668-z","volume":"23","author":"GA Garry","year":"2021","unstructured":"Garry GA, Bezprozvannaya S, Chen K, Zhou H, Hashimoto H, Morales MG, Liu N, Bassel-Duby R, Olson EN. The histone reader PHF7 cooperates with the SWI\/SNF complex at cardiac super enhancers to promote direct reprogramming. Nat Cell Biol. 2021;23:467\u201375. https:\/\/doi.org\/10.1038\/s41556-021-00668-z.","journal-title":"Nat Cell Biol"},{"key":"2079_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.stem.2016.02.003","volume":"18","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wang L, Vaseghi HR, Liu Z, Lu R, Alimohamadi S, Yin C, Fu JD, Wang GG, Liu J, et al. Bmi1 is a key epigenetic barrier to direct cardiac reprogramming. Cell Stem Cell. 2016;18:382\u201395. https:\/\/doi.org\/10.1016\/j.stem.2016.02.003.","journal-title":"Cell Stem Cell"},{"key":"2079_CR51","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.scr.2021.102365","volume":"53","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhao L, Yu X, Zhang J, Qian L, Jin J, Lu R, Zhou Y. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming. Stem Cell Res. 2021;53:102365. https:\/\/doi.org\/10.1016\/j.scr.2021.102365.","journal-title":"Stem Cell Res"},{"key":"2079_CR52","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.1038\/celldisc.2016.36","volume":"2","author":"L Liu","year":"2016","unstructured":"Liu L, Lei I, Karatas H, Li Y, Wang L, Gnatovskiy L, Dou Y, Wang S, Qian L, Wang Z. Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts. Cell Discov. 2016;2:16036. https:\/\/doi.org\/10.1038\/celldisc.2016.36.","journal-title":"Cell Discov"},{"key":"2079_CR53","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.stemcr.2023.05.001","volume":"18","author":"H Kojima","year":"2023","unstructured":"Kojima H, Sadahiro T, Muraoka N, Yamakawa H, Hashimoto H, Ishii R, Gosho M, Abe Y, Yamada Y, Nakano K, et al. MEF2C\/p300-mediated epigenetic remodeling promotes the maturation of induced cardiomyocytes. Stem Cell Rep. 2023;18:1274\u201383. https:\/\/doi.org\/10.1016\/j.stemcr.2023.05.001.","journal-title":"Stem Cell Rep"},{"key":"2079_CR54","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1038\/s41598-022-15559-y","volume":"12","author":"JP Pinnamaneni","year":"2022","unstructured":"Pinnamaneni JP, Singh VP, Kim MB, Ryan CT, Pugazenthi A, Sanagasetti D, Mathison M, Yang J, Rosengart TK. P63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Sci Rep. 2022;12:11416. https:\/\/doi.org\/10.1038\/s41598-022-15559-y.","journal-title":"Sci Rep"},{"key":"2079_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.yjmcc.2013.04.004","volume":"60","author":"RC Addis","year":"2013","unstructured":"Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, Gearhart JD. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol. 2013;60:97\u2013106. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.04.004.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR56","doi-asserted-by":"publisher","first-page":"e63577","DOI":"10.1371\/journal.pone.0063577","volume":"8","author":"N Christoforou","year":"2013","unstructured":"Christoforou N, Chellappan M, Adler AF, Kirkton RD, Wu T, Addis RC, Bursac N, Leong KW. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS ONE. 2013;8:e63577. https:\/\/doi.org\/10.1371\/journal.pone.0063577.","journal-title":"PLoS ONE"},{"key":"2079_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","volume":"1","author":"JD Fu","year":"2013","unstructured":"Fu JD, Stone NR, Liu L, Spencer CI, Qian L, Hayashi Y, Delgado-Olguin P, Ding S, Bruneau BG, Srivastava D. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Rep. 2013;1:235\u201347. https:\/\/doi.org\/10.1016\/j.stemcr.2013.07.005.","journal-title":"Stem Cell Rep"},{"key":"2079_CR58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/circresaha.116.305547","volume":"116","author":"L Wang","year":"2015","unstructured":"Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y, Bursac N, Liu J, Qian L. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res. 2015;116:237\u201344. https:\/\/doi.org\/10.1161\/circresaha.116.305547.","journal-title":"Circ Res"},{"key":"2079_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yjmcc.2023.06.005","volume":"182","author":"M Romero-Tejeda","year":"2023","unstructured":"Romero-Tejeda M, Fonoudi H, Weddle CJ, DeKeyser JM, Lenny B, Fetterman KA, Magdy T, Sapkota Y, Epting CL, Burridge PW. A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state. J Mol Cell Cardiol. 2023;182:30\u201343. https:\/\/doi.org\/10.1016\/j.yjmcc.2023.06.005.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR60","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1073\/pnas.1304053110","volume":"110","author":"R Wada","year":"2013","unstructured":"Wada R, Muraoka N, Inagawa K, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Kaneda R, Suzuki T, Kamiya K, et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci USA. 2013;110:12667\u201372. https:\/\/doi.org\/10.1073\/pnas.1304053110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2079_CR61","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.1073\/pnas.1516237112","volume":"112","author":"H Zhou","year":"2015","unstructured":"Zhou H, Dickson ME, Kim MS, Bassel-Duby R, Olson EN. Akt1\/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes. Proc Natl Acad Sci USA. 2015;112:11864\u20139. https:\/\/doi.org\/10.1073\/pnas.1516237112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2079_CR62","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1161\/circulationaha.122.059713","volume":"146","author":"Y Tang","year":"2022","unstructured":"Tang Y, Aryal S, Geng X, Zhou X, Fast VG, Zhang J, Lu R, Zhou Y. TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming. Circulation. 2022;146:1518\u201336. https:\/\/doi.org\/10.1161\/circulationaha.122.059713.","journal-title":"Circulation"},{"key":"2079_CR63","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.1073\/pnas.1120299109","volume":"109","author":"JF Islas","year":"2012","unstructured":"Islas JF, Liu Y, Weng KC, Robertson MJ, Zhang S, Prejusa A, Harger J, Tikhomirova D, Chopra M, Iyer D, et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci USA. 2012;109:13016\u201321. https:\/\/doi.org\/10.1073\/pnas.1120299109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2079_CR64","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.15252\/embj.201387605","volume":"33","author":"N Muraoka","year":"2014","unstructured":"Muraoka N, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Isomi M, Nakashima H, Akiyama M, Wada R, Inagawa K, et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J. 2014;33:1565\u201381. https:\/\/doi.org\/10.15252\/embj.201387605.","journal-title":"EMBO J"},{"key":"2079_CR65","doi-asserted-by":"publisher","first-page":"e022659","DOI":"10.1161\/jaha.121.022659","volume":"10","author":"VP Singh","year":"2021","unstructured":"Singh VP, Pinnamaneni JP, Pugazenthi A, Sanagasetti D, Mathison M, Martin JF, Yang J, Rosengart TK. Hippo pathway effector Tead1 induces cardiac fibroblast to cardiomyocyte reprogramming. J Am Heart Assoc. 2021;10:e022659. https:\/\/doi.org\/10.1161\/jaha.121.022659.","journal-title":"J Am Heart Assoc"},{"key":"2079_CR66","doi-asserted-by":"publisher","first-page":"8243","DOI":"10.1038\/ncomms9243","volume":"6","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Londono P, Cao Y, Sharpe EJ, Proenza C, O\u2019Rourke R, Jones KL, Jeong MY, Walker LA, Buttrick PM, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun. 2015;6:8243. https:\/\/doi.org\/10.1038\/ncomms9243.","journal-title":"Nat Commun"},{"key":"2079_CR67","doi-asserted-by":"publisher","first-page":"e015686","DOI":"10.1161\/jaha.119.015686","volume":"9","author":"VP Singh","year":"2020","unstructured":"Singh VP, Pinnamaneni JP, Pugazenthi A, Sanagasetti D, Mathison M, Wang K, Yang J, Rosengart TK. Enhanced generation of induced cardiomyocytes using a small-molecule cocktail to overcome barriers to cardiac cellular reprogramming. J Am Heart Assoc. 2020;9:e015686. https:\/\/doi.org\/10.1161\/jaha.119.015686.","journal-title":"J Am Heart Assoc"},{"key":"2079_CR68","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11033-022-07913-0","volume":"50","author":"A Andrianto","year":"2023","unstructured":"Andrianto A, Mulia EPB, Luke K. Direct cardiac reprogramming: basics and future challenges. Mol Biol Rep. 2023;50:865\u201371. https:\/\/doi.org\/10.1007\/s11033-022-07913-0.","journal-title":"Mol Biol Rep"},{"key":"2079_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jacbts.2023.06.012","volume":"9","author":"Q Wang","year":"2024","unstructured":"Wang Q, Spurlock B, Liu J, Qian L. Fibroblast reprogramming in cardiac repair. JACC Basic Transl Sci. 2024;9:145\u201360. https:\/\/doi.org\/10.1016\/j.jacbts.2023.06.012.","journal-title":"JACC Basic Transl Sci"},{"key":"2079_CR70","doi-asserted-by":"publisher","first-page":"e9349","DOI":"10.7759\/cureus.9349","volume":"12","author":"MA Khan","year":"2020","unstructured":"Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi S, AlKatheeri R, Alblooshi FMK, Almatrooshi M, Alzaabi MEH, Al Darmaki RS, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12:e9349. https:\/\/doi.org\/10.7759\/cureus.9349.","journal-title":"Cureus"},{"key":"2079_CR71","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15096.1","author":"M Saleh","year":"2018","unstructured":"Saleh M, Ambrose JA. Understanding myocardial infarction. F1000Res. 2018. https:\/\/doi.org\/10.12688\/f1000research.15096.1.","journal-title":"F1000Res"},{"key":"2079_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","volume":"70","author":"AV Shinde","year":"2014","unstructured":"Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014;70:74\u201382. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.11.015.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR73","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jchf.2017.08.021","volume":"5","author":"MM Kittleson","year":"2017","unstructured":"Kittleson MM, Kobashigawa JA. Cardiac transplantation: current outcomes and contemporary controversies. JACC Heart Fail. 2017;5:857\u201368. https:\/\/doi.org\/10.1016\/j.jchf.2017.08.021.","journal-title":"JACC Heart Fail"},{"key":"2079_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"SB Ong","year":"2018","unstructured":"Ong SB, Hern\u00e1ndez-Res\u00e9ndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, Hausenloy DJ. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001.","journal-title":"Pharmacol Ther"},{"key":"2079_CR75","doi-asserted-by":"publisher","first-page":"149272","DOI":"10.1016\/j.bbrc.2023.149272","volume":"690","author":"Y Abe","year":"2024","unstructured":"Abe Y, Tani H, Sadahiro T, Yamada Y, Akiyama T, Nakano K, Honda S, Ko S, Anzai A, Ieda M. Cardiac reprogramming reduces inflammatory macrophages and improves cardiac function in chronic myocardial infarction. Biochem Biophys Res Commun. 2024;690:149272. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149272.","journal-title":"Biochem Biophys Res Commun"},{"key":"2079_CR76","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1038\/s41598-020-63992-8","volume":"10","author":"G Testa","year":"2020","unstructured":"Testa G, Russo M, Di Benedetto G, Barbato M, Parisi S, Pirozzi F, Tocchetti CG, Abete P, Bonaduce D, Russo T, et al. Bmi1 inhibitor PTC-209 promotes chemically-induced direct cardiac reprogramming of cardiac fibroblasts into cardiomyocytes. Sci Rep. 2020;10:7129. https:\/\/doi.org\/10.1038\/s41598-020-63992-8.","journal-title":"Sci Rep"},{"key":"2079_CR77","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1161\/01.cir.95.3.693","volume":"95","author":"AG Kumar","year":"1997","unstructured":"Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693\u2013700. https:\/\/doi.org\/10.1161\/01.cir.95.3.693.","journal-title":"Circulation"},{"key":"2079_CR78","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","volume":"96","author":"O Dewald","year":"2005","unstructured":"Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881\u20139. https:\/\/doi.org\/10.1161\/01.RES.0000163017.13772.3a.","journal-title":"Circ Res"},{"key":"2079_CR79","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/01.Cir.0000092890.29552.22","volume":"108","author":"S Hayashidani","year":"2003","unstructured":"Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2003;108:2134\u201340. https:\/\/doi.org\/10.1161\/01.Cir.0000092890.29552.22.","journal-title":"Circulation"},{"key":"2079_CR80","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2353\/ajpath.2010.090759","volume":"176","author":"M Dobaczewski","year":"2010","unstructured":"Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG. Ccr5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010;176:2177\u201387. https:\/\/doi.org\/10.2353\/ajpath.2010.090759.","journal-title":"Am J Pathol"},{"key":"2079_CR81","doi-asserted-by":"publisher","first-page":"32660","DOI":"10.1038\/srep32660","volume":"6","author":"Y Huang","year":"2016","unstructured":"Huang Y, Wang D, Wang X, Zhang Y, Liu T, Chen Y, Tang Y, Wang T, Hu D, Huang C. Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction. Sci Rep. 2016;6:32660. https:\/\/doi.org\/10.1038\/srep32660.","journal-title":"Sci Rep"},{"key":"2079_CR82","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/atvbaha.110.206011","volume":"30","author":"F Montecucco","year":"2010","unstructured":"Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, Lerch R, Deruaz M, Proudfoot AE, Mach F. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler Thromb Vasc Biol. 2010;30:1371\u20137. https:\/\/doi.org\/10.1161\/atvbaha.110.206011.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2079_CR83","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.1074\/jbc.RA118.006000","volume":"294","author":"Y Guo","year":"2019","unstructured":"Guo Y, Lei I, Tian S, Gao W, Hacer K, Li Y, Wang S, Liu L, Wang Z. Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming. J Biol Chem. 2019;294:9134\u201346. https:\/\/doi.org\/10.1074\/jbc.RA118.006000.","journal-title":"J Biol Chem"},{"key":"2079_CR84","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41467-019-08626-y","volume":"10","author":"N Muraoka","year":"2019","unstructured":"Muraoka N, Nara K, Tamura F, Kojima H, Yamakawa H, Sadahiro T, Miyamoto K, Isomi M, Haginiwa S, Tani H, et al. Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming. Nat Commun. 2019;10:674. https:\/\/doi.org\/10.1038\/s41467-019-08626-y.","journal-title":"Nat Commun"},{"key":"2079_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2019.05.020","volume":"25","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Liu Z, Welch JD, Gao X, Wang L, Garbutt T, Keepers B, Ma H, Prins JF, Shen W, et al. Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming. Cell Stem Cell. 2019;25:149-164.e149. https:\/\/doi.org\/10.1016\/j.stem.2019.05.020.","journal-title":"Cell Stem Cell"},{"key":"2079_CR86","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvt091","volume":"99","author":"\u00d8 Sandanger","year":"2013","unstructured":"Sandanger \u00d8, Ranheim T, Vinge LE, Bliks\u00f8en M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2013;99:164\u201374. https:\/\/doi.org\/10.1093\/cvr\/cvt091.","journal-title":"Cardiovasc Res"},{"key":"2079_CR87","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349\u201363. https:\/\/doi.org\/10.1038\/nrm809.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2079_CR88","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1172\/jci98215","volume":"128","author":"X Fu","year":"2018","unstructured":"Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD, Sargent MA, Prasad V, Valiente-Alandi I, Blaxall BC, et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest. 2018;128:2127\u201343. https:\/\/doi.org\/10.1172\/jci98215.","journal-title":"J Clin Invest"},{"key":"2079_CR89","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31:659\u201366. https:\/\/doi.org\/10.1093\/eurheartj\/ehq013.","journal-title":"Eur Heart J"},{"key":"2079_CR90","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.jtcvs.2017.06.035","volume":"154","author":"M Mathison","year":"2017","unstructured":"Mathison M, Singh VP, Sanagasetti D, Yang L, Pinnamaneni JP, Yang J, Rosengart TK. Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail. J Thorac Cardiovasc Surg. 2017;154:1601-1610.e1603. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.06.035.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2079_CR91","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"JF Chen","year":"2006","unstructured":"Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38:228\u201333. https:\/\/doi.org\/10.1038\/ng1725.","journal-title":"Nat Genet"},{"key":"2079_CR92","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1101\/gad.1738708","volume":"22","author":"N Liu","year":"2008","unstructured":"Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008;22:3242\u201354. https:\/\/doi.org\/10.1101\/gad.1738708.","journal-title":"Genes Dev"},{"key":"2079_CR93","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fbioe.2020.00529","volume":"8","author":"C Paoletti","year":"2020","unstructured":"Paoletti C, Divieto C, Tarricone G, Di Meglio F, Nurzynska D, Chiono V. Microrna-mediated direct reprogramming of human adult fibroblasts toward cardiac phenotype. Front Bioeng Biotechnol. 2020;8:529. https:\/\/doi.org\/10.3389\/fbioe.2020.00529.","journal-title":"Front Bioeng Biotechnol"},{"key":"2079_CR94","doi-asserted-by":"publisher","first-page":"101310","DOI":"10.1016\/j.bbrep.2022.101310","volume":"31","author":"SS Baksh","year":"2022","unstructured":"Baksh SS, Hodgkinson CP. Conservation of miR combo based direct cardiac reprogramming. Biochem Biophys Rep. 2022;31:101310. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101310.","journal-title":"Biochem Biophys Rep"},{"key":"2079_CR95","doi-asserted-by":"publisher","first-page":"102160","DOI":"10.1016\/j.omtn.2024.102160","volume":"35","author":"X Wang","year":"2024","unstructured":"Wang X, Baksh SS, Pratt RE, Dzau VJ, Hodgkinson CP. Modifying miRs for effective reprogramming of fibroblasts to cardiomyocytes. Mol Ther. 2024;35:102160. https:\/\/doi.org\/10.1016\/j.omtn.2024.102160.","journal-title":"Mol Ther"},{"key":"2079_CR96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yjmcc.2020.12.005","volume":"153","author":"AS Riching","year":"2021","unstructured":"Riching AS, Danis E, Zhao Y, Cao Y, Chi C, Bagchi RA, Klein BJ, Xu H, Kutateladze TG, McKinsey TA, et al. Suppression of canonical TGF-\u03b2 signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis. J Mol Cell Cardiol. 2021;153:44\u201359. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.12.005.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR97","doi-asserted-by":"publisher","DOI":"10.3791\/57687","author":"AS Riching","year":"2018","unstructured":"Riching AS, Zhao Y, Cao Y, Londono P, Xu H, Song K. Suppression of pro-fibrotic signaling potentiates factor-mediated reprogramming of mouse embryonic fibroblasts into induced cardiomyocytes. J Vis Exp JoVE. 2018. https:\/\/doi.org\/10.3791\/57687.","journal-title":"J Vis Exp JoVE"},{"key":"2079_CR98","doi-asserted-by":"publisher","first-page":"105733","DOI":"10.1016\/j.biocel.2020.105733","volume":"122","author":"Y Jia","year":"2020","unstructured":"Jia Y, Chang Y, Sun P, Li H, Guo Z. Inhibition of profibrotic signalling enhances the 5-azacytidine-induced reprogramming of fibroblasts into cardiomyocytes. Int J Biochem Cell Biol. 2020;122:105733. https:\/\/doi.org\/10.1016\/j.biocel.2020.105733.","journal-title":"Int J Biochem Cell Biol"},{"key":"2079_CR99","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/circresaha.117.311045","volume":"121","author":"SA Su","year":"2017","unstructured":"Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, et al. EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-\u03b2\/Smad3 signaling. Circ Res. 2017;121:617\u201327. https:\/\/doi.org\/10.1161\/circresaha.117.311045.","journal-title":"Circ Res"},{"key":"2079_CR100","doi-asserted-by":"publisher","first-page":"109888","DOI":"10.1016\/j.cellsig.2020.109888","volume":"79","author":"IM Reichardt","year":"2021","unstructured":"Reichardt IM, Robeson KZ, Regnier M, Davis J. Controlling cardiac fibrosis through fibroblast state space modulation. Cell Signal. 2021;79:109888. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109888.","journal-title":"Cell Signal"},{"key":"2079_CR101","doi-asserted-by":"publisher","first-page":"608367","DOI":"10.3389\/fcell.2021.608367","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Zhang Y, Xu X, Sun Q, Yang C, Wang H, Yang J, Yang Y, Yang X, Liu Y, et al. Sall4 and Myocd empower direct cardiac reprogramming from adult cardiac fibroblasts after injury. Front Cell Dev Biol. 2021;9:608367. https:\/\/doi.org\/10.3389\/fcell.2021.608367.","journal-title":"Front Cell Dev Biol"},{"key":"2079_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071572","author":"E Bektik","year":"2021","unstructured":"Bektik E, Sun Y, Dennis AT, Sakon P, Yang D, Desch\u00eanes I, Fu JD. Inhibition of CREB-CBP signaling improves fibroblast plasticity for direct cardiac reprogramming. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10071572.","journal-title":"Cells"},{"key":"2079_CR103","doi-asserted-by":"publisher","first-page":"22605","DOI":"10.1038\/s41598-021-02056-x","volume":"11","author":"M Mathison","year":"2021","unstructured":"Mathison M, Sanagasetti D, Singh VP, Pugazenthi A, Pinnamaneni JP, Ryan CT, Yang J, Rosengart TK. Fibroblast transition to an endothelial \u201ctrans\u201d state improves cell reprogramming efficiency. Sci Rep. 2021;11:22605. https:\/\/doi.org\/10.1038\/s41598-021-02056-x.","journal-title":"Sci Rep"},{"key":"2079_CR104","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.7150\/thno.75200","volume":"12","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang F, Hu G, Li X, Wang L, Li C, Huo C, Xu R, Hou L, Wang N, et al. LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction. Theranostics. 2022;12:5824\u201335. https:\/\/doi.org\/10.7150\/thno.75200.","journal-title":"Theranostics"},{"key":"2079_CR105","doi-asserted-by":"publisher","first-page":"300060521101558","DOI":"10.1177\/03000605211015586","volume":"49","author":"H Zhao","year":"2021","unstructured":"Zhao H, Duan L. Cyclic adenosine monophosphate regulates connective tissue growth factor expression in myocardial fibrosis after myocardial infarction. J Int Med Res. 2021;49:3000605211015586. https:\/\/doi.org\/10.1177\/03000605211015586.","journal-title":"J Int Med Res"},{"key":"2079_CR106","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman GJ, Nicol\u00e1s FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type i activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65\u201374. https:\/\/doi.org\/10.1124\/mol.62.1.65.","journal-title":"Mol Pharmacol"},{"key":"2079_CR107","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.stemcr.2015.10.019","volume":"5","author":"H Yamakawa","year":"2015","unstructured":"Yamakawa H, Muraoka N, Miyamoto K, Sadahiro T, Isomi M, Haginiwa S, Kojima H, Umei T, Akiyama M, Kuishi Y, et al. Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions. Stem Cell Rep. 2015;5:1128\u201342. https:\/\/doi.org\/10.1016\/j.stemcr.2015.10.019.","journal-title":"Stem Cell Rep"},{"key":"2079_CR108","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1039\/d0bm00701c","volume":"8","author":"SY Song","year":"2020","unstructured":"Song SY, Kim H, Yoo J, Kwon SP, Park BW, Kim JJ, Ban K, Char K, Park HJ, Kim BS. Prevascularized, multiple-layered cell sheets of direct cardiac reprogrammed cells for cardiac repair. Biomater Sci. 2020;8:4508\u201320. https:\/\/doi.org\/10.1039\/d0bm00701c.","journal-title":"Biomater Sci"},{"key":"2079_CR109","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41551-021-00783-0","volume":"5","author":"J Cho","year":"2021","unstructured":"Cho J, Kim S, Lee H, Rah W, Cho HC, Kim NK, Bae S, Shin DH, Lee MG, Park IH, et al. Regeneration of infarcted mouse hearts by cardiovascular tissue formed via the direct reprogramming of mouse fibroblasts. Nat Biomed Eng. 2021;5:880\u201396. https:\/\/doi.org\/10.1038\/s41551-021-00783-0.","journal-title":"Nat Biomed Eng"},{"key":"2079_CR110","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.celrep.2017.09.005","volume":"20","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wang L, Liu Z, Alimohamadi S, Yin C, Liu J, Qian L. Comparative gene expression analyses reveal distinct molecular signatures between differentially reprogrammed cardiomyocytes. Cell Rep. 2017;20:3014\u201324. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.005.","journal-title":"Cell Rep"},{"key":"2079_CR111","doi-asserted-by":"publisher","first-page":"e14371","DOI":"10.1111\/acel.14371","volume":"24","author":"F Santos","year":"2025","unstructured":"Santos F, Correia M, Dias R, Bola B, Noberini R, Ferreira RS, Trigo D, Domingues P, Teixeira J, Bonaldi T, et al. Age-associated metabolic and epigenetic barriers during direct reprogramming of mouse fibroblasts into induced cardiomyocytes. Aging Cell. 2025;24:e14371. https:\/\/doi.org\/10.1111\/acel.14371.","journal-title":"Aging Cell"},{"key":"2079_CR112","doi-asserted-by":"publisher","first-page":"23017","DOI":"10.1038\/srep23017","volume":"6","author":"X Wang","year":"2016","unstructured":"Wang X, Hodgkinson CP, Lu K, Payne AJ, Pratt RE, Dzau VJ. Selenium augments microRNA directed reprogramming of fibroblasts to cardiomyocytes via Nanog. Sci Rep. 2016;6:23017. https:\/\/doi.org\/10.1038\/srep23017.","journal-title":"Sci Rep"},{"key":"2079_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13287-023-03615-x","volume":"15","author":"J Fang","year":"2024","unstructured":"Fang J, Yang Q, Maas RGC, Buono M, Meijlink B, Lotgerink Bruinenberg D, Benavente ED, Mokry M, van Mil A, Qian L, et al. Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species. Stem Cell Res Ther. 2024;15:19. https:\/\/doi.org\/10.1186\/s13287-023-03615-x.","journal-title":"Stem Cell Res Ther"},{"key":"2079_CR114","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1002\/mco2.70005","volume":"5","author":"Y Nam","year":"2024","unstructured":"Nam Y, Song Y, Seo SJ, Ko GR, Lee SH, Cha E, Kwak SM, Kim S, Shin M, Jin Y, et al. Metabolic reprogramming via mitochondrial delivery for enhanced maturation of chemically induced cardiomyocyte-like cells. MedComm. 2024;5:e70005. https:\/\/doi.org\/10.1002\/mco2.70005.","journal-title":"MedComm"},{"key":"2079_CR115","doi-asserted-by":"publisher","first-page":"115377","DOI":"10.1016\/j.celrep.2025.115377","volume":"44","author":"BM Spurlock","year":"2025","unstructured":"Spurlock BM, Xie Y, Song Y, Ricketts SN, Hua JR, Chi HR, Nishtala M, Salmenov R, Liu J, Qian L. Mitochondrial fusion and cristae reorganization facilitate acquisition of cardiomyocyte identity during reprogramming of murine fibroblasts. Cell Rep. 2025;44:115377. https:\/\/doi.org\/10.1016\/j.celrep.2025.115377.","journal-title":"Cell Rep"},{"key":"2079_CR116","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.ymthe.2025.02.034","volume":"33","author":"Z Jia","year":"2025","unstructured":"Jia Z, Xiang L, Yu Z, Wang L, Fang J, Liu M, Wu X, Lu Z, Wang L. Enhanced fatty acid oxidation via SCD1 downregulation fuels cardiac reprogramming. Mol Ther. 2025;33:1749\u201368. https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.034.","journal-title":"Mol Ther"},{"key":"2079_CR117","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature11044","volume":"485","author":"L Qian","year":"2012","unstructured":"Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485:593\u20138. https:\/\/doi.org\/10.1038\/nature11044.","journal-title":"Nature"},{"key":"2079_CR118","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/jci112160","volume":"76","author":"E Braunwald","year":"1985","unstructured":"Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76:1713\u20139. https:\/\/doi.org\/10.1172\/jci112160.","journal-title":"J Clin Invest"},{"key":"2079_CR119","doi-asserted-by":"publisher","first-page":"967115","DOI":"10.3389\/fcvm.2022.967115","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Gao Y, Li G. Preclinical multi-target strategies for myocardial ischemia-reperfusion injury. Front Cardiovasc Med. 2022;9:967115. https:\/\/doi.org\/10.3389\/fcvm.2022.967115.","journal-title":"Front Cardiovasc Med"},{"key":"2079_CR120","doi-asserted-by":"publisher","first-page":"121028","DOI":"10.1016\/j.biomaterials.2021.121028","volume":"276","author":"Q Wang","year":"2021","unstructured":"Wang Q, Song Y, Chen J, Li Q, Gao J, Tan H, Zhu Y, Wang Z, Li M, Yang H, et al. Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. Biomaterials. 2021;276:121028. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121028.","journal-title":"Biomaterials"},{"key":"2079_CR121","doi-asserted-by":"publisher","first-page":"113228","DOI":"10.1016\/j.yexcr.2022.113228","volume":"418","author":"Y Cao","year":"2022","unstructured":"Cao Y, Dong Z, Yang D, Ma X, Wang X. LSD1 regulates the expressions of core cardiogenic transcription factors and cardiac genes in oxygen and glucose deprivation injured mice fibroblasts in vitro. Exp Cell Res. 2022;418:113228. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113228.","journal-title":"Exp Cell Res"},{"key":"2079_CR122","doi-asserted-by":"publisher","first-page":"934901","DOI":"10.3389\/fphys.2022.934901","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, He Z, Xuan Q, Zhang Y, Xu J, Lin J, Li H, Chen W, Jiang T. Analysis of the potential ferroptosis mechanism and multitemporal expression change of central ferroptosis-related genes in cardiac ischemia-reperfusion injury. Front Physiol. 2022;13:934901. https:\/\/doi.org\/10.3389\/fphys.2022.934901.","journal-title":"Front Physiol"},{"key":"2079_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101432","author":"Q Wang","year":"2023","unstructured":"Wang Q, Zuurbier CJ, Huhn R, Torregroza C, Hollmann MW, Preckel B, van den Brom CE, Weber NC. Pharmacological cardioprotection against ischemia reperfusion injury-the search for a clinical effective therapy. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12101432.","journal-title":"Cells"},{"key":"2079_CR124","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"B Shahim","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global public health burden of heart failure: an updated review. Card Fail Rev. 2023;9:e11. https:\/\/doi.org\/10.15420\/cfr.2023.05.","journal-title":"Card Fail Rev"},{"key":"2079_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3225","author":"C Lenselink","year":"2024","unstructured":"Lenselink C, Ricken K, Groot HE, de Bruijne TJ, Hendriks T, van der Harst P, Voors AA, Lipsic E. Incidence and predictors of heart failure with reduced and preserved ejection fraction after ST-elevation myocardial infarction in the contemporary era of early percutaneous coronary intervention. Eur J Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ejhf.3225.","journal-title":"Eur J Heart Fail"},{"key":"2079_CR126","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ejhf.1406","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur J Heart Fail. 2019;21:272\u201385. https:\/\/doi.org\/10.1002\/ejhf.1406.","journal-title":"Eur J Heart Fail"},{"key":"2079_CR127","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2021.04.121","volume":"560","author":"M Isomi","year":"2021","unstructured":"Isomi M, Sadahiro T, Fujita R, Abe Y, Yamada Y, Akiyama T, Mizukami H, Shu T, Fukuda K, Ieda M. Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage. Biochem Biophys Res Commun. 2021;560:87\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.121.","journal-title":"Biochem Biophys Res Commun"},{"key":"2079_CR128","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/circulationaha.121.058655","volume":"147","author":"H Tani","year":"2023","unstructured":"Tani H, Sadahiro T, Yamada Y, Isomi M, Yamakawa H, Fujita R, Abe Y, Akiyama T, Nakano K, Kuze Y, et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation. 2023;147:223\u201338. https:\/\/doi.org\/10.1161\/circulationaha.121.058655.","journal-title":"Circulation"},{"key":"2079_CR129","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1128\/mcb.01222-08","volume":"29","author":"S Ikeda","year":"2009","unstructured":"Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, et al. Microrna-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29:2193\u2013204. https:\/\/doi.org\/10.1128\/mcb.01222-08.","journal-title":"Mol Cell Biol"},{"key":"2079_CR130","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/iub.2150","volume":"72","author":"MJ V\u00e4lim\u00e4ki","year":"2020","unstructured":"V\u00e4lim\u00e4ki MJ, Ruskoaho HJ. Targeting GATA4 for cardiac repair. IUBMB Life. 2020;72:68\u201379. https:\/\/doi.org\/10.1002\/iub.2150.","journal-title":"IUBMB Life"},{"key":"2079_CR131","doi-asserted-by":"publisher","first-page":"e1001313","DOI":"10.1371\/journal.pgen.1001313","volume":"7","author":"J Schlesinger","year":"2011","unstructured":"Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, T\u00f6njes M, Dunkel I, Sperling SR. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet. 2011;7:e1001313. https:\/\/doi.org\/10.1371\/journal.pgen.1001313.","journal-title":"PLoS Genet"},{"key":"2079_CR132","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2020.08.104","volume":"533","author":"MH Kang","year":"2020","unstructured":"Kang MH, Hu J, Pratt RE, Hodgkinson CP, Asokan A, Dzau VJ. Optimizing delivery for efficient cardiac reprogramming. Biochem Biophys Res Commun. 2020;533:9\u201316. https:\/\/doi.org\/10.1016\/j.bbrc.2020.08.104.","journal-title":"Biochem Biophys Res Commun"},{"key":"2079_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081805","author":"TC Umei","year":"2017","unstructured":"Umei TC, Yamakawa H, Muraoka N, Sadahiro T, Isomi M, Haginiwa S, Kojima H, Kurotsu S, Tamura F, Osakabe R, et al. Single-construct polycistronic doxycycline-inducible vectors improve direct cardiac reprogramming and can be used to identify the critical timing of transgene expression. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18081805.","journal-title":"Int J Mol Sci"},{"key":"2079_CR134","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415\u20139. https:\/\/doi.org\/10.1126\/science.1088547.","journal-title":"Science"},{"key":"2079_CR135","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-physiol-021113-170301","volume":"76","author":"N Muraoka","year":"2014","unstructured":"Muraoka N, Ieda M. Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. Annu Rev Physiol. 2014;76:21\u201337. https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170301.","journal-title":"Annu Rev Physiol"},{"key":"2079_CR136","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346\u201358. https:\/\/doi.org\/10.1038\/nrg1066.","journal-title":"Nat Rev Genet"},{"key":"2079_CR137","doi-asserted-by":"publisher","first-page":"eabj6621","DOI":"10.1126\/sciadv.abj6621","volume":"8","author":"H Kim","year":"2022","unstructured":"Kim H, Song BW, Park SJ, Choi SW, Moon H, Hwang KC, Kang SW, Moon SH, Yang Y, Kwon IC, et al. Ultraefficient extracellular vesicle-guided direct reprogramming of fibroblasts into functional cardiomyocytes. Sci Adv. 2022;8:eabj6621. https:\/\/doi.org\/10.1126\/sciadv.abj6621.","journal-title":"Sci Adv"},{"key":"2079_CR138","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2147\/ijn.S75124","volume":"10","author":"K Lee","year":"2015","unstructured":"Lee K, Yu P, Lingampalli N, Kim HJ, Tang R, Murthy N. Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells. Int J Nanomed. 2015;10:1841\u201354. https:\/\/doi.org\/10.2147\/ijn.S75124.","journal-title":"Int J Nanomed"},{"key":"2079_CR139","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328. https:\/\/doi.org\/10.1038\/nrm.2017.125.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2079_CR140","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","volume":"21","author":"K O'Brien","year":"2020","unstructured":"O\u2019Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21:585\u2013606. https:\/\/doi.org\/10.1038\/s41580-020-0251-y.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2079_CR141","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PR, Andreu Z, Zavec AB, Borr\u00e0s FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. https:\/\/doi.org\/10.3402\/jev.v4.27066.","journal-title":"J Extracell Vesicles"},{"key":"2079_CR142","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389. https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2079_CR143","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14:195\u2013208. https:\/\/doi.org\/10.1038\/nri3622.","journal-title":"Nat Rev Immunol"},{"key":"2079_CR144","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","volume":"8","author":"A Vandergriff","year":"2018","unstructured":"Vandergriff A, Huang K, Shen D, Hu S, Hensley MT, Caranasos TG, Qian L, Cheng K. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics. 2018;8:1869\u201378. https:\/\/doi.org\/10.7150\/thno.20524.","journal-title":"Theranostics"},{"key":"2079_CR145","doi-asserted-by":"publisher","first-page":"105692","DOI":"10.1016\/j.phrs.2021.105692","volume":"170","author":"L Ohayon","year":"2021","unstructured":"Ohayon L, Zhang X, Dutta P. The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease. Pharmacol Res. 2021;170:105692. https:\/\/doi.org\/10.1016\/j.phrs.2021.105692.","journal-title":"Pharmacol Res"},{"key":"2079_CR146","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15252\/emmm.201606924","volume":"9","author":"L Cambier","year":"2017","unstructured":"Cambier L, de Couto G, Ibrahim A, Echavez AK, Valle J, Liu W, Kreke M, Smith RR, Marb\u00e1n L, Marb\u00e1n E. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol Med. 2017;9:337\u201352. https:\/\/doi.org\/10.15252\/emmm.201606924.","journal-title":"EMBO Mol Med"},{"key":"2079_CR147","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/circresaha.117.310752","volume":"120","author":"F Jansen","year":"2017","unstructured":"Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology. Circ Res. 2017;120:1649\u201357. https:\/\/doi.org\/10.1161\/circresaha.117.310752.","journal-title":"Circ Res"},{"key":"2079_CR148","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-020-0389-5","volume":"17","author":"RC de Abreu","year":"2020","unstructured":"de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17:685\u201397. https:\/\/doi.org\/10.1038\/s41569-020-0389-5.","journal-title":"Nat Rev Cardiol"},{"key":"2079_CR149","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135. https:\/\/doi.org\/10.1038\/nbt.1807.","journal-title":"Nat Biotechnol"},{"key":"2079_CR150","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2008.1","volume":"16","author":"S Dai","year":"2008","unstructured":"Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782\u201390. https:\/\/doi.org\/10.1038\/mt.2008.1.","journal-title":"Mol Ther"},{"key":"2079_CR151","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-023-01657-4","volume":"8","author":"A Iyaswamy","year":"2023","unstructured":"Iyaswamy A, Thakur A, Guan XJ, Krishnamoorthi S, Fung TY, Lu K, Gaurav I, Yang Z, Su CF, Lau KF, et al. Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer\u2019s disease. Signal Transduct Target Ther. 2023;8:404. https:\/\/doi.org\/10.1038\/s41392-023-01657-4.","journal-title":"Signal Transduct Target Ther"},{"key":"2079_CR152","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56:836\u201349. https:\/\/doi.org\/10.1038\/s12276-024-01201-6.","journal-title":"Exp Mol Med"},{"key":"2079_CR153","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1007\/s11010-024-05184-w","volume":"480","author":"Y Yao","year":"2025","unstructured":"Yao Y, Yu Y, Xu Y, Liu Y, Guo Z. Enhancing cardiac regeneration: direct reprogramming of fibroblasts into myocardial-like cells using extracellular vesicles secreted by cardiomyocytes. Mol Cell Biochem. 2025;480:3185\u2013200. https:\/\/doi.org\/10.1007\/s11010-024-05184-w.","journal-title":"Mol Cell Biochem"},{"key":"2079_CR154","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.yjmcc.2024.04.002","volume":"190","author":"H Sun","year":"2024","unstructured":"Sun H, Wang X, Pratt RE, Dzau VJ, Hodgkinson CP. C166 EVs potentiate miR cardiac reprogramming via miR-148a-3p. J Mol Cell Cardiol. 2024;190:48\u201361. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.04.002.","journal-title":"J Mol Cell Cardiol"},{"key":"2079_CR155","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","volume":"65","author":"R van der Meel","year":"2013","unstructured":"van der Meel R, Vehmeijer LJ, Kok RJ, Storm G, van Gaal EV. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev. 2013;65:1284\u201398. https:\/\/doi.org\/10.1016\/j.addr.2013.08.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"2079_CR156","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/ijn.S250872","volume":"15","author":"R Pala","year":"2020","unstructured":"Pala R, Anju VT, Dyavaiah M, Busi S, Nauli SM. Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int J Nanomed. 2020;15:3741\u201369. https:\/\/doi.org\/10.2147\/ijn.S250872.","journal-title":"Int J Nanomed"},{"key":"2079_CR157","doi-asserted-by":"publisher","first-page":"1705134","DOI":"10.1002\/adfm.201705134","volume":"28","author":"MPA Ferreira","year":"2018","unstructured":"Ferreira MPA, Talman V, Torrieri G, Liu D, Marques G, Moslova K, Liu Z, Pinto JF, Hirvonen J, Ruskoaho H, et al. Dual-drug delivery using dextran-functionalized nanoparticles targeting cardiac fibroblasts for cellular reprogramming. Adv Funct Mater. 2018;28:1705134. https:\/\/doi.org\/10.1002\/adfm.201705134.","journal-title":"Adv Funct Mater"},{"key":"2079_CR158","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biomaterials.2018.11.034","volume":"192","author":"Y Chang","year":"2019","unstructured":"Chang Y, Lee E, Kim J, Kwon YW, Kwon Y, Kim J. Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier. Biomaterials. 2019;192:500\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.11.034.","journal-title":"Biomaterials"},{"key":"2079_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315179","author":"P Muniyandi","year":"2022","unstructured":"Muniyandi P, Palaninathan V, Hanajiri T, Maekawa T. Direct cardiac epigenetic reprogramming through codelivery of 5\u2019Azacytidine and miR-133a nanoformulation. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232315179.","journal-title":"Int J Mol Sci"},{"key":"2079_CR160","doi-asserted-by":"publisher","first-page":"1901818","DOI":"10.1002\/advs.201901818","volume":"7","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Oh HJ, Park JS, Lee JS, Kim JH, Park KH. Direct conversion of human dermal fibroblasts into cardiomyocyte-like cells using CiCMC nanogels coupled with cardiac transcription factors and a nucleoside drug. Adv Sci. 2020;7:1901818. https:\/\/doi.org\/10.1002\/advs.201901818.","journal-title":"Adv Sci"},{"key":"2079_CR161","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","volume":"343","author":"MJW Evers","year":"2022","unstructured":"Evers MJW, Du W, Yang Q, Kooijmans SAA, Vink A, van Steenbergen M, Vader P, de Jager SCA, Fuchs SA, Mastrobattista E, et al. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. J Control Release. 2022;343:207\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.027.","journal-title":"J Control Release"},{"key":"2079_CR162","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","volume":"32","author":"GT Noble","year":"2014","unstructured":"Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol. 2014;32:32\u201345. https:\/\/doi.org\/10.1016\/j.tibtech.2013.09.007.","journal-title":"Trends Biotechnol"},{"key":"2079_CR163","doi-asserted-by":"publisher","first-page":"19464","DOI":"10.1038\/srep19464","volume":"6","author":"A Kawamura","year":"2016","unstructured":"Kawamura A, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ito E, Watabe T, Masuda S, Toda K, Hatazawa J, et al. Teratocarcinomas arising from allogeneic induced pluripotent stem cell-derived cardiac tissue constructs provoked host immune rejection in mice. Sci Rep. 2016;6:19464. https:\/\/doi.org\/10.1038\/srep19464.","journal-title":"Sci Rep"},{"key":"2079_CR164","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"YW Liu","year":"2018","unstructured":"Liu YW, Chen B, Yang X, Fugate JA, Kalucki FA, Futakuchi-Tsuchida A, Couture L, Vogel KW, Astley CA, Baldessari A, et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol. 2018;36:597\u2013605. https:\/\/doi.org\/10.1038\/nbt.4162.","journal-title":"Nat Biotechnol"},{"key":"2079_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13811","author":"D Chang","year":"2024","unstructured":"Chang D, Sun C, Tian X, Liu H, Jia Y, Guo Z. Regulation of cardiac fibroblasts reprogramming into cardiomyocyte-like cells with a cocktail of small molecule compounds. FEBS Open Bio. 2024. https:\/\/doi.org\/10.1002\/2211-5463.13811.","journal-title":"FEBS Open Bio"},{"key":"2079_CR166","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.7150\/thno.35574","volume":"9","author":"SY Song","year":"2019","unstructured":"Song SY, Yoo J, Go S, Hong J, Sohn HS, Lee JR, Kang M, Jeong GJ, Ryu S, Kim SHL, et al. Cardiac-mimetic cell-culture system for direct cardiac reprogramming. Theranostics. 2019;9:6734\u201344. https:\/\/doi.org\/10.7150\/thno.35574.","journal-title":"Theranostics"},{"key":"2079_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061513","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Villalpando J, Zhang W, Nam YJ. Chamber-specific protein expression during direct cardiac reprogramming. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061513.","journal-title":"Cells"},{"key":"2079_CR168","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583\u20138. https:\/\/doi.org\/10.1038\/nature14136.","journal-title":"Nature"},{"key":"2079_CR169","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth.2598","volume":"10","author":"ML Maeder","year":"2013","unstructured":"Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013;10:977\u20139. https:\/\/doi.org\/10.1038\/nmeth.2598.","journal-title":"Nat Methods"},{"key":"2079_CR170","doi-asserted-by":"publisher","first-page":"e0223842","DOI":"10.1371\/journal.pone.0223842","volume":"14","author":"S Dal-Pra","year":"2019","unstructured":"Dal-Pra S, Hodgkinson CP, Dzau VJ. Induced cardiomyocyte maturation: cardiac transcription factors are necessary but not sufficient. PLoS ONE. 2019;14:e0223842. https:\/\/doi.org\/10.1371\/journal.pone.0223842.","journal-title":"PLoS ONE"},{"key":"2079_CR171","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.apsb.2019.09.003","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang X, Zhao L, Zuo S, Chen X, Zhang L, Lin Z, Zhao X, Qin Y, Zhou X, et al. Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR\/Cas9-based transcriptional activators. Acta Pharm Sin B. 2020;10:313\u201326. https:\/\/doi.org\/10.1016\/j.apsb.2019.09.003.","journal-title":"Acta Pharm Sin B"},{"key":"2079_CR172","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liang J, Huang W, Ma J, Park KH, Wu Z, Chen P, Zhu H, Ma JJ, Cai W, et al. CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Mol Ther. 2022;30:54\u201374. https:\/\/doi.org\/10.1016\/j.ymthe.2021.10.015.","journal-title":"Mol Ther"},{"key":"2079_CR173","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jtcvs.2020.05.040","volume":"163","author":"T Sano","year":"2022","unstructured":"Sano T, Ito T, Ishigami S, Bandaru S, Sano S. Intrinsic activation of cardiosphere-derived cells enhances myocardial repair. J Thorac Cardiovasc Surg. 2022;163:1479-1490.e1475. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.05.040.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2079_CR174","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.stem.2019.06.012","volume":"25","author":"NR Stone","year":"2019","unstructured":"Stone NR, Gifford CA, Thomas R, Pratt KJB, Samse-Knapp K, Mohamed TMA, Radzinsky EM, Schricker A, Ye L, Yu P, et al. Context-specific transcription factor functions regulate epigenomic and transcriptional dynamics during cardiac reprogramming. Cell Stem Cell. 2019;25:87-102.e109. https:\/\/doi.org\/10.1016\/j.stem.2019.06.012.","journal-title":"Cell Stem Cell"},{"key":"2079_CR175","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/cvr\/cvab134","volume":"118","author":"L Wang","year":"2022","unstructured":"Wang L, Yang Y, Ma H, Xie Y, Xu J, Near D, Wang H, Garbutt T, Li Y, Liu J, et al. Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes. Cardiovasc Res. 2022;118:1548\u201363. https:\/\/doi.org\/10.1093\/cvr\/cvab134.","journal-title":"Cardiovasc Res"},{"key":"2079_CR176","doi-asserted-by":"publisher","first-page":"e14271","DOI":"10.1111\/apha.14271","volume":"241","author":"OO Piven","year":"2025","unstructured":"Piven OO, Vai\u010diulevi\u010di\u016bt\u0117 R, Bernotiene E, Dobrzyn P. Cardiomyocyte engineering: the meeting point of transcription factors, signaling networks, metabolism and function. Acta Physiol. 2025;241:e14271. https:\/\/doi.org\/10.1111\/apha.14271.","journal-title":"Acta Physiol"},{"key":"2079_CR177","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature24454","volume":"551","author":"Z Liu","year":"2017","unstructured":"Liu Z, Wang L, Welch JD, Ma H, Zhou Y, Vaseghi HR, Yu S, Wall JB, Alimohamadi S, Zheng M, et al. Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte. Nature. 2017;551:100\u20134. https:\/\/doi.org\/10.1038\/nature24454.","journal-title":"Nature"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02079-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:52:57Z","timestamp":1767199977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02079-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":177,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02079-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"114"}}